Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Journal of Basic and Clinical Physiology and Pharmacology|April 15, 2025
Anions, Membrane Resistance and Ventricular FibrillationMichael J Curtis, Paul D RidleyJournal of Cardiothoracic Surgery|November 9, 2006
Use of intraventricular ribbon gauze to reduce particulate emboli during aortic valve replacementMahmoud Loubani, Daniel Von Petius, Paul D RidleyJournal of Pharmacological and Toxicological Methods|February 27, 2010
Troubleshooting pharmacological and toxicological methodsMichael J CurtisThe Journal of Heart Valve Disease|February 24, 2007
Silzone-coated St. Jude Medical valves: six-year experience in 46 patientsUday P Dandekar, Max Baghai, Maninder Kalkat, et al.Journal of Cardiovascular Pharmacology|February 28, 2002
Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat heartsAndrás Farkas, Michael J CurtisJournal of Cardiovascular Pharmacology|October 25, 2003
Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing?András Farkas, Michael J CurtisBritish Journal of Pharmacology|May 30, 2013
Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoidsEllen Andrag, Michael J CurtisBritish Journal of Pharmacology|April 7, 2004
Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonismKathryn E Baker, Michael J CurtisPharmacology Research & Perspectives|August 4, 2015
Replication - why we need to publish our findingsMichael J Curtis, Darrell R AbernethyPharmacology & Therapeutics|August 28, 2014
Potential role of cardiac chloride channels and transporters as novel therapeutic targetsGabrielle B Adkins, Michael J CurtisPageof 8